{
    "Trade/Device Name(s)": [
        "QuickVue\u00ae RSV test"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K061008",
    "Predicate Device Reference 510(k) Number(s)": [
        "K032166"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "MCE"
    ],
    "Summary Letter Date": "August 17, 2006",
    "Summary Letter Received Date": "August 21, 2006",
    "Submission Date": "April 11, 2006",
    "Regulation Number(s)": [
        "21CFR866.3480"
    ],
    "Regulation Name(s)": [
        "Respiratory syncytial virus serological reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Respiratory syncytial virus (RSV) antigen"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab",
        "Nasopharyngeal aspirate",
        "Nasal wash"
    ],
    "Specimen Container(s)": [
        "Extraction tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Test strip"
    ],
    "Method(s)/Technology(ies)": [
        "Lateral-flow immunoassay"
    ],
    "Methodologies": [
        "Immunoassay",
        "Antigen detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Reagent",
        "Dipstick"
    ],
    "Document Summary": "FDA 510(k) summary for Quidel QuickVue\u00ae RSV lateral-flow immunoassay for rapid detection of RSV antigen in nasopharyngeal specimens.",
    "Indications for Use Summary": "Rapid, qualitative detection of RSV antigen from nasopharyngeal swab, aspirate, or nasal wash in symptomatic patients aged 18 years or younger, as an aid in diagnosing acute RSV infections; negative results should be confirmed by cell culture.",
    "fda_folder": "Microbiology"
}